Kilitch Drugs Standalone March 2022 Net Sales at Rs 32.03 crore, up 51.49% Y-o-Y
2 months ago•Moneycontrol
Kilitch Drugs commences Rs100 crore new facility expansion plan
5 months ago•India Infoline
Kilitch Drugs (India) reports standalone net profit of Rs 2.89 crore in the June 2021 quarter
1 year ago•Business Standard
Kilitch Drugs starts production of Cephalosporin Injectables at Ethiopia Plant; Stock surges 5%
1 year ago•India Infoline
Kilitch Drugs (India) reports consolidated net profit of Rs 0.71 crore in the March 2021 quarter
1 year ago•Business Standard
Buzzing Stocks | Bharti Airtel, RIL, Railtel, Bank Of Maharashtra, Equitas Holdings, Tata Chemicals, Hindustan Aeronautics
1 year ago•Moneycontrol
Board of Kilitch Drugs (India) approves change in CFO and company secretary
1 year ago•Business Standard
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value